COVID-19 vaccination - summary for immunisation providers


The Australian Government Department of Health and Aged Care website now has a dedicated page for Clinical guidance for COVID-19 vaccine providers. This page has the latest updates from the Australian Technical Advisory Group on Immunisation (ATAGI), clinical information, COVID-19 vaccines doses and recommendations, vaccine efficacy and effectiveness, and additional clinical considerations. 

Additional information is provided below (Last updated: 16 December 2022):

COVID-19 vaccine safety surveillance 

  • AusVaxSafety

    AusVaxSafety is conducting comprehensive active safety monitoring of all COVID-19 vaccines being used in Australia. The latest safety surveillance data report on adverse events following COVID-19 vaccination for all participants, including Aboriginal and Torres Strait Islander people. Over 6.3 million participants have responded to surveys, with 44.4% reporting an adverse event following COVID-19 vaccination. Most common adverse events include injection site pain, fatigue, headache and other expected side effects following immunisation. 

    Related resource: AusVaxSafety COVID-19 vaccine safety surveillance


  • Therapeutic Goods Administration

    The TGA is closely monitoring suspected adverse events following vaccination with COVID-19 vaccines in use in Australia. The latest weekly safety report of the TGA provides detailed information about the reported side effects for COVID-19 vaccines, total adverse event reports, reporting rates per 1000 doses by jurisdiction, and most commonly reported vaccine side effects.  

    The most frequently reported suspected side effects continue to be events that were seen in the clinical trials and are commonly experienced with vaccines generally. 

    Related resource: TGA COVID-19 vaccine safety weekly report


Variants of concern

Answering patients' questions and concerns about COVID-19 vaccines

Case numbers and statistics